Diagnostics company adds staff, sets up shop in Claymont

271
Advertisement

Birkmeyer webCD Diagnostics, Inc., an immunoassay developer and manufacturer, announced the addition of new hires to its research and development team as it formally opens its new headquarters and R&D center in Claymont.

The company is headed by Richard Birmeyer, a founder of Strategic Diagnostics, a Newark company that has sold its operating assets. The move from the Route 202 corridor in Pennsylvania consolidated administrative, research and development, and manufacturing operations under one roof. CD received $500,000 Strategic Grant from the state in return for creating 170 jobs by 2016.

Since the signing of its first corporate partnership with Zimmer, a leading provider of orthopaedic devices and implants, CD Diagnostics has initiated more programs to expand its pipeline of assays for use in orthopaedics, as well as the development of assays for other non-related applications.

Martin Gould joins the company as an Immunoassay Development Fellow. Gould is a biomedical scientist with more than 40 years of experience in the diagnostic and chemical fields. He is a researcher with  publications in a variety of fields, including rapid immunoassay tests to detect food pathogens such as E-coli, salmonella, listeria, shigella, and campylobacter.

He was awarded a patent in composition for stabilization of diagnostics reagents, three separate patents for immunoassay diagnostic kits, as well as a patent describing a growth media that resuscitates injured bacteria.

Advertisement

James W. Stave, Ph.D. joins the senior management team as Vice President of Corporate Development and Antibody Research Fellow. Prior to joining CD Diagnostics, Stave was a Senior Research Fellow at Strategic Diagnostics. He has experience as a public biotechnology company business executive and as a  immunoassay product development scientist. Jim has held positions as Chief Scientific Officer, Vice President of Research and Development, and Senior Research Fellow, and is responsible for the development of over 30 commercial test products.

His fields of expertise include technology commercialization, product development, biotechnology and immunology.

“As we expand the number of programs that we are simultaneously working on and prepare for our relocation to Delaware, the addition of these individuals creates a very strong R&D team with more experience in point of care technology than could be found in most big companies,” said Rick Birkmeyer, CEO of CD Diagnostics, Inc.

“We are very fortunate to have attracted such talent.” “I am very excited to be working with such a talented and dedicated team of professionals where my technical and business development experience can accelerate ongoing programs and create new opportunities for growth,” says Stave.

Martin Gould says, “Being involved with this exciting new technology is a unique and exciting challenge. Seeing the tests that we are commercializing positively impacting patients’ lives is very rewarding.” Today, government officials will join company officials and guests will hold a ribbon cutting at the facility. CD also has an office in New Jersey and a laboratory in Baltimore.

Advertisement
Advertisement

1 COMMENT

  1. Dear hiring manager,
    I was searching the web for employment in the pharmaceutical manufacturing field and cane across this job opportunity in Claymont De.
    It caught eye and seems to be a Match for me
    In the manufacturing department. I was quite excited because I found a job opportunity very
    Close to where I live., I did send my resume and
    I hope to hear from the hiring manager. I just wanted to share this with you.
    Thanks so much,
    Carol Nickson

Comments are closed.